Synopsis
Synopsis
0
KDMF
0
VMF
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
Annual Reports
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers


1. Q418006
| Molecular Weight | 331.9 g/mol |
|---|---|
| Molecular Formula | C21H30ClN |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 1 |
| Rotatable Bond Count | 6 |
| Exact Mass | 331.2066777 g/mol |
| Monoisotopic Mass | 331.2066777 g/mol |
| Topological Polar Surface Area | 0 Ų |
| Heavy Atom Count | 23 |
| Formal Charge | 0 |
| Complexity | 300 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |

API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
83
PharmaCompass offers a list of Cholestyramine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cholestyramine manufacturer or Cholestyramine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cholestyramine manufacturer or Cholestyramine supplier.
PharmaCompass also assists you with knowing the Cholestyramine API Price utilized in the formulation of products. Cholestyramine API Price is not always fixed or binding as the Cholestyramine Price is obtained through a variety of data sources. The Cholestyramine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A CHOLESTYRAMINE LIGHT manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of CHOLESTYRAMINE LIGHT, including repackagers and relabelers. The FDA regulates CHOLESTYRAMINE LIGHT manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. CHOLESTYRAMINE LIGHT API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of CHOLESTYRAMINE LIGHT manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A CHOLESTYRAMINE LIGHT supplier is an individual or a company that provides CHOLESTYRAMINE LIGHT active pharmaceutical ingredient (API) or CHOLESTYRAMINE LIGHT finished formulations upon request. The CHOLESTYRAMINE LIGHT suppliers may include CHOLESTYRAMINE LIGHT API manufacturers, exporters, distributors and traders.
click here to find a list of CHOLESTYRAMINE LIGHT suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A CHOLESTYRAMINE LIGHT DMF (Drug Master File) is a document detailing the whole manufacturing process of CHOLESTYRAMINE LIGHT active pharmaceutical ingredient (API) in detail. Different forms of CHOLESTYRAMINE LIGHT DMFs exist exist since differing nations have different regulations, such as CHOLESTYRAMINE LIGHT USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A CHOLESTYRAMINE LIGHT DMF submitted to regulatory agencies in the US is known as a USDMF. CHOLESTYRAMINE LIGHT USDMF includes data on CHOLESTYRAMINE LIGHT's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The CHOLESTYRAMINE LIGHT USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of CHOLESTYRAMINE LIGHT suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The CHOLESTYRAMINE LIGHT Drug Master File in Japan (CHOLESTYRAMINE LIGHT JDMF) empowers CHOLESTYRAMINE LIGHT API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the CHOLESTYRAMINE LIGHT JDMF during the approval evaluation for pharmaceutical products. At the time of CHOLESTYRAMINE LIGHT JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of CHOLESTYRAMINE LIGHT suppliers with JDMF on PharmaCompass.
A CHOLESTYRAMINE LIGHT CEP of the European Pharmacopoeia monograph is often referred to as a CHOLESTYRAMINE LIGHT Certificate of Suitability (COS). The purpose of a CHOLESTYRAMINE LIGHT CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of CHOLESTYRAMINE LIGHT EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of CHOLESTYRAMINE LIGHT to their clients by showing that a CHOLESTYRAMINE LIGHT CEP has been issued for it. The manufacturer submits a CHOLESTYRAMINE LIGHT CEP (COS) as part of the market authorization procedure, and it takes on the role of a CHOLESTYRAMINE LIGHT CEP holder for the record. Additionally, the data presented in the CHOLESTYRAMINE LIGHT CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the CHOLESTYRAMINE LIGHT DMF.
A CHOLESTYRAMINE LIGHT CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. CHOLESTYRAMINE LIGHT CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of CHOLESTYRAMINE LIGHT suppliers with CEP (COS) on PharmaCompass.
A CHOLESTYRAMINE LIGHT written confirmation (CHOLESTYRAMINE LIGHT WC) is an official document issued by a regulatory agency to a CHOLESTYRAMINE LIGHT manufacturer, verifying that the manufacturing facility of a CHOLESTYRAMINE LIGHT active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting CHOLESTYRAMINE LIGHT APIs or CHOLESTYRAMINE LIGHT finished pharmaceutical products to another nation, regulatory agencies frequently require a CHOLESTYRAMINE LIGHT WC (written confirmation) as part of the regulatory process.
click here to find a list of CHOLESTYRAMINE LIGHT suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing CHOLESTYRAMINE LIGHT as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for CHOLESTYRAMINE LIGHT API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture CHOLESTYRAMINE LIGHT as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain CHOLESTYRAMINE LIGHT and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a CHOLESTYRAMINE LIGHT NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of CHOLESTYRAMINE LIGHT suppliers with NDC on PharmaCompass.
CHOLESTYRAMINE LIGHT Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of CHOLESTYRAMINE LIGHT GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right CHOLESTYRAMINE LIGHT GMP manufacturer or CHOLESTYRAMINE LIGHT GMP API supplier for your needs.
A CHOLESTYRAMINE LIGHT CoA (Certificate of Analysis) is a formal document that attests to CHOLESTYRAMINE LIGHT's compliance with CHOLESTYRAMINE LIGHT specifications and serves as a tool for batch-level quality control.
CHOLESTYRAMINE LIGHT CoA mostly includes findings from lab analyses of a specific batch. For each CHOLESTYRAMINE LIGHT CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
CHOLESTYRAMINE LIGHT may be tested according to a variety of international standards, such as European Pharmacopoeia (CHOLESTYRAMINE LIGHT EP), CHOLESTYRAMINE LIGHT JP (Japanese Pharmacopeia) and the US Pharmacopoeia (CHOLESTYRAMINE LIGHT USP).